Compare IONQ Inc (IONQ) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IONQ Inc vs Nuvation Bio Inc. Class A Common Stock — how do they compare? IONQ Inc trades at $40.22 (market cap $16.75B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: IONQ Inc is far larger — about 9.8× Nuvation Bio Inc. Class A Common Stock's market cap, and IONQ Inc is more actively traded (18,768,450 versus 5,448,712). Which is the better fit depends on your goals — on Pluang, investors hold IONQ Inc for 33 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| IONQ | NUVB | |
|---|---|---|
Market Cap | $16.75B | $1.71B |
Volume | 18,768,450 | 5,448,712 |
Sector | Technology | Health |
52-Week High | $82.09 | $9.54 |
52-Week Low | $26.59 | $3.41 |
Typical Hold Time | 33 Days | 0 Days |
Enterprise Value | $14.68B | $1.30B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IONQ trades at $41.34, down 4.5% today, with a mixed technical picture showing bullish oscillators but bearish moving averages. The company reported strong revenue growth to $130M in 2025 but faces significant losses with a -553% net income margin. Recent analyst coverage from Bank of America initiated with a Buy rating and $60 target, highlighting the company's semiconductor-based quantum computing approach and partnerships with major cloud providers.
While IONQ shows promising technology and analyst support with a consensus $62.75 price target representing 52% upside, investors face substantial risks from ongoing losses, negative cash flow from operations, and high valuation multiples. The stock's performance hinges on successful commercialization of quantum technology and achieving profitability targets in the coming years.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About IONQ Inc
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
